N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate
![N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate Structure](CAS/20210111/GIF/960055-68-9.gif)
- CAS No.
- 960055-68-9
- Chemical Name:
- N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate
- Synonyms
- Panobinostat Lactate;N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate
- CBNumber:
- CB23152214
- Molecular Formula:
- C24H29N3O5
- Molecular Weight:
- 439.51
- MDL Number:
- MOL File:
- 960055-68-9.mol
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate Properties
| FDA UNII | HN0T99OO4V |
|---|---|
| NCI Drug Dictionary | panobinostat lactate |
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate Chemical Properties,Uses,Production
Description
Panobinostat lactate is a histone deacetylase (HDAC) inhibitor that was approved by the FDA for the treatment of multiple myeloma. It was also approved for the same indication in Japan, and the EU approved its use in combination with bortezomib and dexamethasone for the treatment of adults with relapsed and/or refractory multiple myeloma. Panobinostat was discovered and developed by Novartis and is currently being investigated for a number of hematological cancers as well as other indications.
Synthesis
Grandberg synthesis of 2-methyltryptamine (223) was accomplished in 47% yield by heating phenylhydrazine (221) with 5-chloro-2-pentanone (222). Reductive amination of 223 with (E)-3-(4-formyl-phenyl)-acrylic acid methyl ester (224) and sodium borohydride followed by formation of the hydrochloride salt provided amine hydrochloride 225 in high purity. Saponification of the methyl ester followed by reaction with hydroxylamine provided panobinostat in high overall yield. The free base was treated with racemic lactic acid and recrystallized in water to give panobinostat lactate (XXVIII).
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate Preparation Products And Raw materials
Raw materials
Preparation Products
N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide DL-lactate monohydrate Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Lynnchem | 86-(0)29-85992781 17792393971 | info@lynnchem.com | China | 4587 | 58 |
| Novachemistry | 44-20819178-90 02081917890 | info@novachemistry.com | United Kingdom | 4381 | 58 |
| Supplier | Advantage |
|---|---|
| Lynnchem | 58 |
| Novachemistry | 58 |